UPL has received approval to buy-back 1.40 crore fully paid-up equity shares of Rs 2 each at a price not exceeding Rs 220 per equity share, payable in cash upto an aggregate amount not exceeding Rs 308 crore from the open market through Stock Exchange(s). The board at its meeting held on December 30, 2013 has approved for the same.
UPL has reported around 2 fold jump in its net profit at Rs 165.13 crore for the second quarter ended September 30, 2013 as compared to Rs 78.85 crore for the same quarter in the previous year. Total income of the company has increased by 56.23% at Rs 1460.34 crore for quarter under review as compared to Rs 934.72 crore for the quarter ended September 30, 2012.
| Company Name | CMP |
|---|---|
| UPL | 594.00 |
| PI Industries | 2800.45 |
| Bayer CropScience | 4215.50 |
| Sharda Cropchem | 875.95 |
| Sumitomo Chemical | 447.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: